BIM
AMRI

BlackRock Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

BlackRock Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.59M Buy
137,904
+21,794
+19% +$370K ﹤0.01% 2047
2016
Q3 		$1.92M Sell
116,110
-2,228
-2% -$33K ﹤0.01% 2193
2016
Q2 		$1.59M Buy
118,338
+18,190
+18% +$265K ﹤0.01% 2296
2016
Q1 		$1.53M Sell
100,148
-209
-0.2% -$3.28K ﹤0.01% 2177
2015
Q4 		$1.99M Buy
100,357
+928
+0.9% +$17.6K ﹤0.01% 2087
2015
Q3 		$1.73M Buy
99,429
+329
+0.3% +$6.7K ﹤0.01% 2176
2015
Q2 		$2M Buy
99,100
+7,855
+9% +$152K ﹤0.01% 2229
2015
Q1 		$1.61M Buy
91,245
+700
+0.8% +$11.9K ﹤0.01% 2185
2014
Q4 		$1.47M Sell
90,545
-916
-1% -$16.8K ﹤0.01% 2270
2014
Q3 		$2.02M Buy
91,461
+3,105
+4% +$63.6K ﹤0.01% 1995
2014
Q2 		$1.78M Buy
88,356
+8,441
+11% +$143K ﹤0.01% 2172
2014
Q1 		$1.49M Buy
79,915
+726
+0.9% +$10K ﹤0.01% 2240
2013
Q4 		$798K Sell
79,189
-2,123
-3% -$25.7K ﹤0.01% 2664
2013
Q3 		$1.05M Buy
81,312
+2,591
+3% +$31.9K ﹤0.01% 2406
2013
Q2 		$934K Buy
+78,721
New +$853K ﹤0.01% 2412

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

BlackRock Investment Management's AMRI Position: Q4 2016 in Review

BlackRock Investment Management increased its Albany Molecular Research Inc (AMRI) stake by 19% in Q4 2016, buying an estimated $370K and bringing the position to 137,904 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

BlackRock Investment Management first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • BlackRock Investment Management held 137,904 shares of Albany Molecular Research Inc worth $2.59M as of Q4 2016.
  • BlackRock Investment Management bought 21,794 Albany Molecular Research Inc shares in Q4 2016, an estimated $370K.
  • Albany Molecular Research Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2047 holding.
  • BlackRock Investment Management first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.